Published in Br J Pharmacol on November 01, 1995
Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A (1999) 2.13
Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci U S A (1997) 1.11
Store-operated Ca2+ entry in sensory neurons: functional role and the effect of painful nerve injury. J Neurosci (2011) 1.09
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils. Proc Natl Acad Sci U S A (1997) 0.95
On the selectivity of neuronal NOS inhibitors. Br J Pharmacol (2013) 0.84
Role of GABA receptors in nitric oxide inhibition of dorsolateral periaqueductal gray neurons. Neuropharmacology (2008) 0.80
Coactivation of NMDA receptors by glutamate and D-serine induces dilation of isolated middle cerebral arteries. J Cereb Blood Flow Metab (2011) 0.80
Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br J Pharmacol (1996) 0.79
Effects of nitric oxide synthase inhibition in the dorsolateral periaqueductal gray matter on ethanol withdrawal-induced anxiety-like behavior in rats. Psychopharmacology (Berl) (2013) 0.79
NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1. J Exp Med (2015) 0.78
Selective inhibition of thapsigargin-induced contraction and capacitative calcium entry in mouse anococcygeus by trifluoromethylphenylimidazole (TRIM). Br J Pharmacol (2001) 0.77
Nitric Oxide Synthase Inhibitors as Antidepressants. Pharmaceuticals (Basel) (2010) 0.75
7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol (1993) 1.97
Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem (1994) 1.52
Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J Biol Chem (1994) 1.48
Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol (1993) 1.47
Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. J Biol Chem (1993) 1.13
Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent? Trends Biotechnol (1995) 0.98
Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta. Br J Pharmacol (1995) 0.90
Postinfectious fatigue: prospective cohort study in primary care. Lancet (1995) 5.21
Population based study of fatigue and psychological distress. BMJ (1994) 5.15
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol (1988) 3.54
Teenagers' health concerns: implications for primary health care professionals. J R Coll Gen Pract (1989) 3.00
Use of a questionnaire in general practice to increase the recognition of patients with excessive alcohol consumption. Br Med J (Clin Res Ed) (1985) 2.85
L-NG-monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br J Pharmacol (1990) 2.84
Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract (2001) 2.76
Can telemedicine be used to improve communication between primary and secondary care? BMJ (1996) 2.55
What are safe levels of alcohol consumption? Br Med J (Clin Res Ed) (1984) 2.54
L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol (1991) 2.53
The risk of alcohol. Addiction (1993) 2.51
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health (1997) 2.47
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
A pilot study of sexual lifestyle in a random sample of the population of Great Britain. AIDS (1989) 2.13
Safe limits of drinking: general practitioners' views. Br Med J (Clin Res Ed) (1985) 2.06
The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol (2002) 2.05
7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol (1993) 1.97
beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol (1994) 1.97
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care (1992) 1.92
In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest (1986) 1.87
Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract (1995) 1.86
Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci (2008) 1.84
The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab (1997) 1.82
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest (1998) 1.82
Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol (2006) 1.68
Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol (1993) 1.66
Down your drink: a web-based intervention for people with excessive alcohol consumption. Alcohol Alcohol (2003) 1.62
Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion. BMJ (2003) 1.62
Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels. Br J Pharmacol (1988) 1.59
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport (1994) 1.56
Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis. Br J Pharmacol (1978) 1.47
Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol (1993) 1.47
Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatry (1996) 1.45
Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J Clin Invest (1986) 1.43
Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes (1986) 1.41
A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br J Pharmacol (1998) 1.41
Pathways of prostaglandin F2alpha metabolism in mammalian kidneys. Br J Pharmacol (1977) 1.40
Coping with patients' problem drinking. Practitioner (1989) 1.39
Blood pressure, smoking, obesity and alcohol consumption in black and white patients in general practice. J Hum Hypertens (1987) 1.38
Embedding guidelines into direct physician order entry: simple methods, powerful results. Proc AMIA Symp (1999) 1.37
Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest (1990) 1.36
An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus. Br J Pharmacol (1992) 1.33
Squamous cell carcinoma of the eyelids. Br J Ophthalmol (2002) 1.29
The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol (1991) 1.28
Performance of different mono- and multiplex nucleic acid amplification tests on a multipathogen external quality assessment panel. J Clin Microbiol (2011) 1.27
Genetic linkage between Huntington's disease and the DNA polymorphism G8 in South Wales families. J Med Genet (1985) 1.25
Linking up with the over 75s. Br J Gen Pract (1990) 1.25
Patients with alcohol problems--simple questioning is the key to effective identification and management. Br J Gen Pract (2001) 1.24
Anti-inflammatory steroids reduce tissue PG synthetase activity and enhance PG breakdown. Nature (1980) 1.22
Chronic fatigue in general practice: economic evaluation of counselling versus cognitive behaviour therapy. Br J Gen Pract (2001) 1.21
Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo. Eur J Pharmacol (1988) 1.21
Capacitative Ca2+ entry and the regulation of smooth muscle tone. Trends Pharmacol Sci (1998) 1.18
Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab (1990) 1.18
Cardiovascular effects of urotensin II in anesthetized and pithed rats. Gen Comp Endocrinol (1986) 1.17
Long term survival after intensive care. BMJ (1990) 1.17
Synergistic anti-nociceptive effect of L-NG-nitro arginine methyl ester (L-NAME) and flurbiprofen in the mouse. Br J Pharmacol (1992) 1.14
Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle. Br J Pharmacol (1980) 1.11
Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med (1988) 1.10
An exploratory study of language interpretation services provided by videoconferencing. J Telemed Telecare (2003) 1.10
The effect of drugs on various parameters of mouse behaviour in a modified head-dipping test [proceedings]. Br J Pharmacol (1976) 1.09
Pathophysiological states modify levels in rat plasma of factors which inhibit synthesis and enhance breakdown of PG. Nature (1980) 1.08
Anode/cathode make and break phenomena in a model of defibrillation. IEEE Trans Biomed Eng (1999) 1.08
Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol (1990) 1.08
Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol (2002) 1.08
7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase. Life Sci (1995) 1.07
The future role of telemedicine at the interface between primary and secondary care. J Telemed Telecare (1996) 1.05
A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin. Br J Pharmacol (2000) 1.05
Nitroparacetamol exhibits anti-inflammatory and anti-nociceptive activity. Br J Pharmacol (2000) 1.04
Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflamm Res (2008) 1.02
Multicentre quality control study for detection of Mycobacterium tuberculosis in clinical samples by nucleic amplification methods. Clin Microbiol Infect (2004) 1.02
An overview of the biological significance of endogenous gases: new roles for old molecules. Biochem Soc Trans (2007) 1.01
The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney. Br J Pharmacol (1989) 1.01
Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes (1987) 1.01
Linking education, research, and service in general practice. BMJ (1998) 1.00
Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lung. Br J Pharmacol (1986) 0.99
Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent? Trends Biotechnol (1995) 0.98
A comparison of the effect of nitroparacetamol and paracetamol on liver injury. Br J Pharmacol (2001) 0.97
A multi-centre pilot proficiency programme to assess the quality of molecular detection of respiratory viruses. J Clin Virol (2005) 0.97
Human plasma contains prostaglandin 'reciprocal coupling factor'. Eur J Pharmacol (1980) 0.97
Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology (1998) 0.97
Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes (1990) 0.96
Effects of aging on glucose-mediated glucose disposal and glucose transport. J Clin Invest (1986) 0.96
Health checks for people aged 75 and over. Occas Pap R Coll Gen Pract (1993) 0.95
Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care (1993) 0.95
A nociceptive-intensity-dependent role for hydrogen sulphide in the formalin model of persistent inflammatory pain. Neuroscience (2008) 0.94
Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes (1998) 0.94
Correlation between store-operated cation current and capacitative Ca2+ influx in smooth muscle cells from mouse anococcygeus. Eur J Pharmacol (1999) 0.93
Essential role for nitric oxide in neurogenic inflammation in rat cutaneous microcirculation. Evidence for an endothelium-independent mechanism. Circ Res (1995) 0.91
Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol (1987) 0.91
Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmacol (1988) 0.90
Prostaglandins and mechanism of action of sulphasalazine in ulcerative colitis. Lancet (1978) 0.90
Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA. J Pharm Pharmacol (1993) 0.89
A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer. Int J Oncol (1999) 0.89
Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes (1990) 0.89
Dermatomyofibroma: a report of two cases, one occurring in a child. Australas J Dermatol (2001) 0.89